ASCRS 2024 is on the horizon, and our DMEI team is gearing up for some well-deserved time in the spotlight to share our advancements and findings in canaloplasty.
I must take a moment to express how proud I am of our fellows and residents. This year, we're thrilled to bring the groundbreaking #iTrack #canaloplasty technology into focus with an array of presentations: 6 podium presentations, 1 presented poster and 2 e-Posters. Each session will offer nuanced insights into the clinical outcomes and the versatile applications of canaloplasty in managing #glaucoma.
Below is a summary of our group representatives’ presentations scheduled in the ASCRS's official scientific program – be sure not to miss them!
PODIUM PRESENTATIONS
Saturday, April 6, 2024 @ BCEC - Meeting Level 2, Room 259A
Ahmad Abdel-Aty, MD
Ab-Interno Canaloplasty in Primary Angle-Closure Spectrum+
Time: 10:10 AM
Raman Michael, MD
Investigating the Consistency in Outcomes of Ab-Interno Canaloplasty
as a Standalone Procedure
Time: 10:15 AM
Neal Rangu, BA; Mohsain Gill, MD; Kamran Riaz, MD; Mahmoud A. Khaimi, MD
Performing Ab-Interno Canaloplasty Post Keratoplasty in Steroid-Induced Glaucoma Eyes – 3 Years Outcomes
Time: 10:20 AM
Sunday, April 7, 2024 @ BCEC - Meeting Level 2, Room 259A
Umar D. Sandhu, BA; Kamran M. Riaz, MD; Mahmoud A. Khaimi, MD
Performing Ab-Interno Canaloplasty Post Keratoplasty – 2 Year Outcomes
Time: 08:40 AM
Juliana Bryant, MD
Ab-Interno Canaloplasty Standalone Versus Combined with Cataract Surgery – 36-Month Outcomes in +1000 Eyes
Time: 4:39 PM
Manish Harrigill, MD
Performing Ab-Interno Canaloplasty in PACG Eyes Across Different Stages of Glaucoma Severity
Time: 4:54 PM
PRESENTED POSTER
Saturday, April 6, 2024 @ BCEC - Poster Presentation Area
Juliana Bryant, MD
Canaloplasty MIGS Characteristics: Correlation between Pressurized OVD Volume and Effectiveness on IOP and Medications in PACG Eyes
Time: 2:15 PM
e-POSTERS
Raman A. Michael, MD
Canaloplasty Performed with an Ab-Interno Technique for Pseudoexfoliative or Pigmentary Glaucoma Eyes – 12 Months Results
Raman A. Michael, MD
Effectiveness and Safety Profile of Standalone Ab-Interno Canaloplasty Using the iTrack in Uncontrolled (>18mmHg) Glaucoma Eyes
#ASCRS2024 #iTrack #MIGS #Ophthalmology #GlaucomaTreatment
#ASCRS2024 #iTrack #MIGS #Ophthalmology #GlaucomaTreatment
American Society of Cataract and Refractive Surgery (ASCRS)
Dean McGee Eye Institute